Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin receptor ligands: A pharmaco‐chemical perspective
Jean A. Boutin, Paula A. Witt‐Enderby, Christoph Sotriffer, et al.
Journal of Pineal Research (2020) Vol. 69, Iss. 3
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression
Eunsoo Won, Kyoung‐Sae Na, Yong‐Ku Kim
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 305-305
Open Access | Times Cited: 79
Structural basis of the ligand binding and signaling mechanism of melatonin receptors
Qinggong Wang, Qiuyuan Lu, Qiong Guo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Revisiting the role of melatonin in human melanocyte physiology: A skin context perspective
Alec Sevilla, Jérémy Chéret, Radomir M. Slominski, et al.
Journal of Pineal Research (2022) Vol. 72, Iss. 3
Open Access | Times Cited: 39
Melatonin controversies, an update
Jean A. Boutin, Ralf Jockers
Journal of Pineal Research (2020) Vol. 70, Iss. 2
Closed Access | Times Cited: 52
A novel mechanism for the protection against acute lung injury by melatonin: mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2
Ning Li, Rui Xiong, Guorui Li, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Closed Access | Times Cited: 35
Role of circadian rhythms and melatonin in bladder function in heath and diseases
Stewart Ramsay, Vladimir Zagorodnyuk
Autonomic Neuroscience (2023) Vol. 246, pp. 103083-103083
Closed Access | Times Cited: 13
Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease
Violina T. Angelova, B. Georgiev, Tania Pencheva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1194-1194
Open Access | Times Cited: 13
The potential remedy of melatonin on osteoarthritis
Ko‐Hsiu Lu, Peace Wun‐Ang Lu, Eric Lu, et al.
Journal of Pineal Research (2021) Vol. 71, Iss. 3
Open Access | Times Cited: 28
Melatonin and its Emerging Physiological Role in Reproduction: A Review and Update
Ruifeng Shao, Ying Wang, Chihua He, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 4, pp. 449-456
Closed Access | Times Cited: 10
Molecular Characterization and Pharmacology of Melatonin Receptors in Animals
Erika Cecon, Jean A. Boutin, Ralf Jockers
Receptors (2023) Vol. 2, Iss. 2, pp. 127-147
Open Access | Times Cited: 9
Melatonin Regulates Lipid Metabolism in Porcine Cumulus–Oocyte Complexes via the Melatonin Receptor 2
Jun‐Xue Jin, Jing‐Tao Sun, Chaoqian Jiang, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 687-687
Open Access | Times Cited: 15
Neural plasticity and depression treatment
Yubing Wang, Ning‐Ning Song, Yu‐Qiang Ding, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 160-184
Open Access | Times Cited: 15
Melatonin and Related Compounds as Antioxidants
Alexia Barbarossa, Antonio Carrieri, Alessia Carocci
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 546-565
Closed Access | Times Cited: 7
The location, physiology, pathology of hippocampus Melatonin MT2 receptor and MT2-selective modulators
Yueqin Feng, Xiaowen Jiang, Wenwu Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115888-115888
Closed Access | Times Cited: 7
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.
Journal of Pineal Research (2024) Vol. 76, Iss. 2
Open Access | Times Cited: 2
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder
Jinmei Ye, Cong Duan, Jiaxin Han, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 6, pp. 1541-1554
Open Access | Times Cited: 2
Shumian Capsule Improves the Sleep Disorder and Mental Symptoms Through Melatonin Receptors in Sleep-Deprived Mice
Wenhua Li, Yinlong Cheng, Yi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Production of functional sperm from <i>in vitro</i>-cultured premeiotic spermatogonia in a marine fish
Hong Zhang, Wanwan Zhang, Chengyu Mo, et al.
动物学研究 (2022) Vol. 43, Iss. 4, pp. 537-551
Open Access | Times Cited: 11
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities
Luana M. Manosso, Luciano A. Duarte, Nicoly S. Martinello, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 9, pp. 1085-1100
Closed Access | Times Cited: 6
In silico drug discovery of melatonin receptor ligands with therapeutic potential
Gian Marco Elisi, Laura Scalvini, Alessio Lodola, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 4, pp. 343-354
Closed Access | Times Cited: 8
Why Are We Still Cloning Melatonin Receptors? A Commentary
Célia Gautier, Isabelle Théret, Giulia Lizzo, et al.
Methods in molecular biology (2022), pp. 267-281
Closed Access | Times Cited: 8
Melatonin’s Impact on Wound Healing
Eun‐Hwa Sohn, Su‐Nam Kim, Sung Ryul Lee
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1197-1197
Open Access | Times Cited: 1
Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats
Marcos Antonio Ferreira, Hátylas Azevedo, Alessandra Mascarello, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 1904-1929
Open Access | Times Cited: 11
Melatonin as a Promising Agent for Cancer Treatment: Insights into its Effects on the Wnt/beta-catenin Signaling Pathway
Amirhossein Davoodvandi, Reza Asemi, Mehran Sharifi, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 11, pp. 1315-1331
Closed Access | Times Cited: 4
Melatonin–vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat
Youssef Y. Helmi, Niklas Papenkordt, Georg Alexander Rennar, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 9
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top